- Challenging the Feasibility and Clinical Significance of Current Guidelines on Lymph Node Examination in Rectal Cancer in the Era of Neoadjuvant Therapy
[作者：Govindarajan, A; Gonen, M; Weiser, MR; Shia, J; Temple, LK; Guillem, JG; Paty, PB; Nash, GM,期刊：Journal of clinical oncology, 页码：4568-4573 , 文章类型： Article，,卷期：2011年29-34]
- Purpose We sought to examine the feasibility and clinical significance of current guidelines on nodal assessment in patients with rectal cancer (RC) treated with neoadjuvant radiation. Methods All patients with RC treate...
- Eight-Signature Classifier for Prediction of Nasopharnyngeal Carcinoma Survival
[作者：Wang, HY; Sun, BY; Zhu, ZH; Chang, ET; To, KF; Hwang, JSG; Jiang, H; Kam, MKM; Chen, G; Cheah, SL; Lee, M; Liu, ZW; Chen, J; Zhang, JX; Zhang, HZ; He, JH; Chen, FL; Zhu, XD; Huang, MY; Liao, DZ; Fu, J; Shao, Q; Cai, MB; Du, ZM; Yan, LX; Hu, CF; Ng, HK; Wee, JTS; Qian, CN; Liu, Q; Ernberg, I; Ye, WM; Adami, HO; Chan, AT; Zeng, YX; Shao, JY,期刊：Journal of clinical oncology, 页码：4516-4524 , 文章类型： Article，,卷期：2011年29-34]
- Purpose Currently, nasopharyngeal carcinoma (NPC) prognosis evaluation is based primarily on the TNM staging system. This study aims to identify prognostic markers for NPC. Patients and Methods We detected expression of ...
- Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry
[作者：Kurian, AW; Gong, GD; John, EM; Johnston, DA; Felberg, A; West, DW; Miron, A; Andrulis, IL; Hopper, JL; Knight, JA; Ozcelik, H; Dite, GS; Apicella, C; Southey, MC; Whittemore, AS,期刊：Journal of clinical oncology, 页码：4505-4509 , 文章类型： Article，,卷期：2011年29-34]
- Purpose Women with germline BRCA1 and BRCA2 mutations have five- to 20-fold increased risks of developing breast and ovarian cancer. A recent study claimed that women testing negative for their family-specific BRCA1 or B...
- Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer
[作者：Stockler, MR; Harvey, VJ; Francis, PA; Byrne, MJ; Ackland, SP; Fitzharris, B; Van Hazel, G; Wilcken, NRC; Grimison, PS; Nowak, AK; Gainford, MC; Fong, A; Paksec, L; Sourjina, T; Zannino, D; Gebski, V; Simes, RJ; Forbes, JF; Coates, AS,期刊：Journal of clinical oncology, 页码：4498-4504 , 文章类型： Article，,卷期：2011年29-34]
- Purpose We compared oral capecitabine, administered intermittently or continuously, versus classical cyclophosphamide, methotrexate, and fluorouracil (CMF) as first-line chemotherapy for women with advanced breast cancer...
- Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
[作者：Lai, A; Kharbanda, S; Pope, WB; Tran, A; Solis, OE; Peale, F; Forrest, WF; Pujara, K; Carrillo, JA; Pandita, A; Ellingson, BM; Bowers, CW; Soriano, RH; Schmidt, NO; Mohan, S; Yong, WH; Seshagiri, S; Modrusan, Z; Jiang, ZS; Aldape, KD; Mischel, PS; Liau, LM; Escovedo, CJ; Chen, WD; Nghiemphu, PL; James, CD; Prados, MD; Westphal, M; Lamszus, K; Cloughesy, T; Phillips, HS,期刊：Journal of clinical oncology, 页码：4482-4490 , 文章类型： Article; Proceedings Paper，,卷期：2011年29-34]
- Purpose Mutation in isocitrate dehydrogenase 1 (IDH1) at R132 (IDH1(R132MUT)) is frequent in low-grade diffuse gliomas and, within glioblastoma (GBM), has been proposed as a marker for GBMs that arise by transformation f...
- Post-Traumatic Stress Symptoms in Long-Term Non-Hodgkin's Lymphoma Survivors: Does Time Heal?
[作者：Smith, SK; Zimmerman, S; Williams, CS; Benecha, H; Abernethy, AP; Mayer, DK; Edwards, LJ; Ganz, PA,期刊：Journal of clinical oncology, 页码：4526-4533 , 文章类型： Article，,卷期：2011年29-34]
- Purpose Little is known about the trajectory of post-traumatic stress disorder (PTSD) symptoms in cancer survivors, despite the fact that such knowledge can guide treatment. Therefore, this study examined changes in PTSD...
- Preliminary Efficacy of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
[作者：Juergens, H; Daw, NC; Geoerger, B; Ferrari, S; Villarroel, M; Aerts, I; Whelan, J; Dirksen, U; Hixon, ML; Yin, DH; Wang, T; Green, S; Paccagnella, L; Gualberto, A,期刊：Journal of clinical oncology, 页码：4534-4540 , 文章类型： Article，,卷期：2011年29-34]
- Purpose Patients with Ewing sarcoma (ES) with metastases and those who relapse fare poorly and receive therapies that carry significant toxicity. This phase 1/2 study was conducted to evaluate the efficacy of figitumumab...
- Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
[作者：Von Hoff, DD; Ramanathan, RK; Borad, MJ; Laheru, DA; Smith, LS; Wood, TE; Korn, RL; Desai, N; Trieu, V; Iglesias, JL; Zhang, H; Soon-Shiong, P; Shi, T; Rajeshkumar, NV; Maitra, A; Hidalgo, M,期刊：Journal of clinical oncology, 页码：4548-4554 , 文章类型： Article，,卷期：2011年29-34]
- Purpose The trial objectives were to identify the maximum-tolerated dose (MTD) of first-line gemcitabine plus nab-paclitaxel in metastatic pancreatic adenocarcinoma and to provide efficacy and safety data. Additional obj...
|